Literature DB >> 9715735

Decreased pulmonary vascular resistance during nasal breathing: modulation by endogenous nitric oxide from the paranasal sinuses.

G Settergren1, M Angdin, R Astudillo, S Gelinder, J Liska, J O Lundberg, E Weitzberg.   

Abstract

Nitric oxide is present in high concentration in the human nasal airways. During inspiration through the nose a bolus is transported to the lungs. In a randomized cross-over study the effect of two different patterns of breathing, nasal breathing and mouth breathing, was evaluated in 10 patients (mean age 65 years), breathing room air the morning of the first post-operative day after open heart surgery. Nasal breathing is defined as inspiration through the nose and expiration through the mouth, whilst mouth breathing is the converse of this: inspiration through the mouth and expiration through the nose. Pressure in the pulmonary artery and left atrium or pulmonary artery wedge was measured together with thermodilution cardiac output and arterial and mixed venous oxygenation and acid-base parameters. Pulmonary vascular resistance index (PVRI), venous admixture and alveolar-arterial gradient were calculated. Nasal breathing resulted in a lower PVRI, 256 dyn s cm-5 cm-2 vs. 287 (P < 0.01). The oxygen and carbon dioxide tension and pH of arterial and mixed venous blood, venous admixture and the alveolar-arterial gradient remained unchanged. The decreased level of PVRI during nasal breathing compared to that during mouth breathing supports the notion, that endogenous nitric oxide acts as an airborne messenger to modulate the pulmonary vascular tone during normal breathing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9715735     DOI: 10.1046/j.1365-201x.1998.00352.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  2 in total

Review 1.  Nasal nitric oxide in man.

Authors:  J O Lundberg; E Weitzberg
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  Biomarkers of hypoxia, endothelial and circulatory dysfunction among climbers in Nepal with AMS and HAPE: a prospective case-control study.

Authors:  Kevin R Barker; Andrea L Conroy; Michael Hawkes; Holly Murphy; Prativa Pandey; Kevin C Kain
Journal:  J Travel Med       Date:  2016-03-16       Impact factor: 8.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.